Over SEK 130 million for medical research
.webp)
Medfarm and Uppsala University was awarded large grants from the Swedish Research Council. Photo: Mikael Wallerstedt
Uppsala University has once again performed well in the Swedish Research Council’s funding calls in medicine and health. A total of 27 research projects have been awarded grants.
Josefin Sveen, researcher at the Department of Women's and Children's Health, was awarded grants fron the Swedish Research Council. She was also awarded grants by FORTE just a few days ago.
The Swedish Research Council has now announced its funding decisions in the field of medicine and health. Uppsala University has been awarded a total of SEK 134,483,430.
In addition to project grants, starting grants and network grants were also awarded. A total of 27 research projects received funding from the Swedish Research Council.
Cancer, antibiotic resistance and molecular medicine
The projects awarded funding within the Disciplinary Domain of Medicine and Pharmacy cover a wide range of research areas. In terms of funding, three projects stand out, each receiving SEK 8.5 million over five years.
Dan I Andersson, Professor at the Department of Medical Biochemistry and Microbiology, received funding for the project "Evolution and medical consequences of heteroresistance".
Ulf Landegren, Professor at the Department of Immunology, Genetics and Pathology, was awarded funding for the project "Technologies for large-scale molecular medicine".
Fredrik Swartling, Professor at the Department of Immunology, Genetics and Pathology, received funding for the project "Tumour evolution and relapse models in organoids and targeting SOX9 in brain tumours".
Online treatment for prolonged grief
Also worth noting is that Josefin Sveen, researcher at the Department of Women's and Children's Health, received funding for the project "Internet-based treatment for prolonged grief disorder: Efficacy and mechanisms of action in a randomised study of cognitive behavioural therapy". Just a few days earlier, she had also been awarded funding in Forte's major call for project grants.
“It feels absolutely fantastic, and at the same time a relief, to have secured funding for another three years. It means a great deal for our research. We have already started a randomised controlled trial, and thanks to the grants, we can now expand the study to include several clinics,” says Josefin Sveen.